Addressing hyperglycemia from hospital admission to discharge

References

• American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615
   PubMed Web of Science ®Google Scholar
• Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004;27:553-91
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82
   PubMed Web of Science ®Google Scholar
• Campbell RK. Etiology and effect on outcomes of hyperglycemia in hospitalized patients. Am J Health Sys Pharm 2007;64:S4-8
   PubMed Web of Science ®Google Scholar
• Asadollahi K, Beeching N, Gill G. Hyperglycaemia and mortality. J R Soc Med 2007;100:503-7
   PubMed Web of Science ®Google Scholar
• Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 2002;288:2579-88
   PubMed Web of Science ®Google Scholar
• Williams LS, Rotich J, Qi R, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002;59:67-71
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-8
   PubMed Web of Science ®Google Scholar
• Estrada CA, Young JA, Nifong LW, et al. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg 2003;75:1392-9
   PubMed Web of Science ®Google Scholar
• Pomposelli JJ, Baxter III JK, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998;22:77-81
   PubMed Web of Science ®Google Scholar
• Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8
   PubMed Web of Science ®Google Scholar
• Moghissi ES, Kongable GL, Abad VJ, et al. Current state of inpatient diabetes burden and care, and goal of the conference. Endocr Pract 2006;12:1-10
   PubMedGoogle Scholar
• Olson L, Muchmore J, Lawrence CB. The benefits of inpatient diabetes care: improving quality of care and the bottom line. Endocr Pract 2006;12(Suppl 3):35-42
   PubMedGoogle Scholar
• Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract 2006;12(Suppl 3):43-8
   PubMedGoogle Scholar
• Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67
   PubMed Web of Science ®Google Scholar
• Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004;10:77-82
   PubMedGoogle Scholar
• ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control. Endocr Pract 2006;12:458-68
   PubMedGoogle Scholar
• American Diabetes Association. Standards of medical care in diabetes – 2009. Diabetes Care 2009;32(Suppl 1):S13-61
   PubMed Web of Science ®Google Scholar
• Moghissi ES, Korytkowski MT, Dinardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control. Endocr Pract 2009;15:1-17
   Web of Science ®Google Scholar
• Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-61
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 2004;79:992-1000
   PubMed Web of Science ®Google Scholar
• Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008;300:933-44
   PubMed Web of Science ®Google Scholar
• Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-97
   PubMed Web of Science ®Google Scholar
• Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009;180:821-7
   PubMed Web of Science ®Google Scholar
• Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39
   PubMed Web of Science ®Google Scholar
• De La Rosa GC, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008;12:R120
   PubMed Web of Science ®Google Scholar
• Ahmann AJ. Inpatient management of hospitalized patients with type 2 diabetes. Curr Diab Rep 2004;4:346-51
   PubMedGoogle Scholar
• Ku SY, Sayre CA, Hirsch IB, et al. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt Comm J Qual Patient Saf 2005;31:141-7
   PubMedGoogle Scholar
• Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004;27:461-7
   PubMed Web of Science ®Google Scholar
• Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract 2002;8:10-18
   PubMedGoogle Scholar
• Portland Diabetic Project. Portland protocol 2008. Available at: http://www.providence.org/oregon/programs_and_services/heart/portlandprotocol
   Google Scholar
• Furnary AP, Cheek DB, Holmes SC, et al. Achieving tight glycemic control in the operating room: lessons learned from 12 years in the trenches of a paradigm shift in anesthetic care. Semin Thorac Cardiovasc Surg 2006;18:339-45
   PubMedGoogle Scholar
• Maynard G, O’Malley CW, Kirsh SR. Perioperative care of the geriatric patient with diabetes or hyperglycemia. Clin Geriatr Med 2008;24:649-65
   PubMed Web of Science ®Google Scholar
• Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-32
   PubMed Web of Science ®Google Scholar
• Zarich SW. Mechanism by which hyperglycemia plays a role in the setting of acute cardiovascular illness. Rev Cardiovasc Med 2006;7(Suppl 2):S35-43
   PubMedGoogle Scholar
• McAlister FA, Majumdar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 2005;28:810-15
   PubMed Web of Science ®Google Scholar
• Furnary AP, Zerr KJ, Grunkemeier GL, et al. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-60
   PubMed Web of Science ®Google Scholar
• Furnary AP, Wu Y. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract 2006;12(Suppl 3):22-6
   PubMedGoogle Scholar
• Meneghini LF. Perioperative management of diabetes: translating evidence into practice. Cleve Clin J Med 2009;76(Suppl 4):S53-9
   PubMedGoogle Scholar
• Maynard G, Lee J, Phillips G, et al. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J Hosp Med 2009;4:3-15
   PubMed Web of Science ®Google Scholar
• Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 2006;98:557-64
   PubMed Web of Science ®Google Scholar
• Magee MF. Hospital protocols for targeted glycemic control: development, implementation, and models for cost justification. Am J Health Sys Pharm 2007;64:S15-20
   PubMed Web of Science ®Google Scholar
• Donaldson S, Villanuueva G, Rondinelli L, et al. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. Diabetes Educ 2006;32:954-62
   PubMed Web of Science ®Google Scholar
• Magee MF, Clement S. Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract 2004;10(Suppl 2):81-8
   PubMedGoogle Scholar
• Moghissi E. Hospital management of diabetes: beyond the sliding scale. Cleve Clin J Med 2004;71:801-8
   PubMed Web of Science ®Google Scholar
• Moghissi ES, Hirsch IB. Hospital management of diabetes. Endocrinol Metab Clin North Am 2005;34:99-116
   PubMed Web of Science ®Google Scholar
• Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab 2003;88:2430-7
   PubMed Web of Science ®Google Scholar
• Cook CB, Stockton L, Baird M, et al. Working to improve care of hospital hyperglycemia through statewide collaboration: the Georgia Hospital Association Diabetes Special Interest Group. Endocr Pract 2007;13:45-50
   PubMedGoogle Scholar
• Reynolds LR, Cook AM, Lewis DA, et al. An institutional process to improve inpatient glycemic control. Qual Manag Health Care 2007;16:239-49
   PubMedGoogle Scholar
• Cohen LS, Sedhom L, Salifu M, et al. Inpatient diabetes management: examining morning practice in an acute care setting. Diabetes Educ 2007;33:483-92
   PubMed Web of Science ®Google Scholar
• Lubitz CC, Seley JJ, Rivera C, et al. The perils of inpatient hyperglycemia management: how we turned apathy into action. Diabetes Spectr 2007;20:18-21
   Google Scholar
• DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract 2006;12:491-505
   PubMedGoogle Scholar
• Baldwin D, Villanueva G, McNutt R, et al. Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff. Diabetes Care 2005;28:1008-11
   PubMed Web of Science ®Google Scholar
• Huffman M. Health coaching: a new and exciting technique to enhance patient self-management and improve outcomes. Home Healthc Nurse 2007;25:271-4
   PubMedGoogle Scholar
• Mullen BA, Kelley PA. Diabetes nurse case management: an effective tool. J Am Acad Nurse Pract 2006;18:22-30
   PubMed Web of Science ®Google Scholar
• Hirsch IB. Sliding scale insulin – time to stop sliding. JAMA 2009;301:213-14
   PubMed Web of Science ®Google Scholar
• Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997;157:545-52
   PubMed Web of Science ®Google Scholar
• Golightly LK, Jones MA, Hamamura DH, et al. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy 2006;26:1421-32
   PubMed Web of Science ®Google Scholar
• Wexler DJ, Meigs JB, Cagliero E, et al. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care 2007;30:367-9
   PubMed Web of Science ®Google Scholar
• Becker T, Moldoveanu A, Cukierman T, et al. Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia. Diabetes Res Clin Pract 2007;78:392-7
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 2007;30:2181-6
   PubMed Web of Science ®Google Scholar
• Schnipper JL, Ndumele CD, Liang CL, et al. Effects of a subcutaneous insulin protocol, clinical education, and computerized order set on the quality of inpatient management of hyperglycemia: results of a clinical trial. J Hosp Med 2009;4:16-27
   PubMed Web of Science ®Google Scholar
• Chapman TM, Perry CM. Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus. Drugs 2004;64:2577-95
   PubMed Web of Science ®Google Scholar
• Morales J. Defining the role of insulin detemir in basal insulin therapy. Drugs 2007;67:2557-84
   PubMed Web of Science ®Google Scholar
• Dunn CJ, Plosker GL, Keating GM, et al. Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs 2003;63:1743-78
   PubMed Web of Science ®Google Scholar
• Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009;15:540-59
   PubMed Web of Science ®Google Scholar
• Reynolds NA, Wagstaff AJ. Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus. Drugs 2004;64:1957-74
   PubMed Web of Science ®Google Scholar
• Robinson DM, Wellington K. Insulin glulisine. Drugs 2006;66:861-9
   PubMed Web of Science ®Google Scholar
• Simpson D, McCormack PL, Keating GM, et al. Insulin lispro: a review of its use in the management of diabetes mellitus. Drugs 2007;67:407-34
   PubMed Web of Science ®Google Scholar
• Brunton SA. Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs. Med Gen Med 2007;9:38
   PubMedGoogle Scholar
• Rossetti P, Porcellati F, Bolli GB, et al. Prevention of hypoglycemia while achieving good glycemic control in type 1 diabetes: the role of insulin analogs. Diabetes Care 2008;31(Suppl 2):S113-20
   PubMed Web of Science ®Google Scholar
• Davis S, Alonso MD. Hypoglycemia as a barrier to glycemic control. J Diabetes Complications 2004;18:60-8
   PubMed Web of Science ®Google Scholar
• Fulcher GR, Gilbert RE, Yue DK. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy. Intern Med J 2005;35:536-42
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Dailey G, Massi-Benedetti M, et al. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005;28:950-5
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H. The relationship between glycemic control and hypoglycemia using insulin glargine versus NPH insulin: a meta-regression analysis in type 2 diabetes. Diabetes 2003;52(Suppl 1):A149-50
   PubMedGoogle Scholar
• Raslova K, Bogoev M, Raz I, et al. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract 2004;66:193-201. [Correction appears in Raslova K, et al. Diabetes Res Clin Pract. 2006;72:112]
   PubMed Web of Science ®Google Scholar
• Haak T, Tiengo A, Draeger E, et al. Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes. Diabetes Obes Metab 2005;7:56-64
   PubMed Web of Science ®Google Scholar
• Hermansen K, Davies M, Derezinski T, et al. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care 2006;29:1269-74
   PubMed Web of Science ®Google Scholar
• Heinemann L. Variability of insulin absorption and insulin action. Diabetes Technol Ther 2002;4:673-82
   PubMedGoogle Scholar
• Ratner RE, Hirsch IB, Neifing JL, et al. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care 2000;23:639-43
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H, Dressler A, Ziemen M, et al. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 2000;23:1130-6
   PubMed Web of Science ®Google Scholar
• Bartley PC, Bogoev M, Larsen J, et al. Long-term efficacy and safety of insulin detemir compared to neutral protamine Hagedorn insulin in patients with type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial. Diabet Med 2008;25:442-9
   PubMed Web of Science ®Google Scholar
• Heise T, Pieber TR. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab 2007;9:648-59
   PubMed Web of Science ®Google Scholar
• Home PD, Lindholm A, Hylleberg B, et al. Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. Diabetes Care 1998;21:1904-9
   PubMed Web of Science ®Google Scholar
• Anderson JH Jr, Brunelle RL, Koivisto VA, et al. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes 1997;46:265-70
   PubMed Web of Science ®Google Scholar
• Dailey G, Rosenstock J, Moses RG, et al. Insulin glulisine provides improved glycemic control in patients with type 2 diabetes. Diabetes Care 2004;27:2363-8
   PubMed Web of Science ®Google Scholar
• Heller SR, Amiel SA, Mansell P. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy. U.K. Lispro Study Group. Diabetes Care 1999;22:1607-11
   PubMed Web of Science ®Google Scholar
• Gale EAM. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with type 1 diabetes on intensified insulin therapy. Diabet Med 2000;17:209-14
   PubMed Web of Science ®Google Scholar
• Heller S, Colagiuri S, Vaaler S, et al. Reduced hypoglycemia with insulin aspart: a double-blind, randomized crossover trial in type 1 diabetic patients. Diabetes 2001;50:A137
   Web of Science ®Google Scholar
• Bottomley JM, Raymond FD. Pharmaco-economic issues for diabetes therapy. Best Pract Res Clin Endocrinol Metab 2007;21:657-85
   PubMed Web of Science ®Google Scholar
• Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006;355:1903-11
   PubMed Web of Science ®Google Scholar
• Fonseca V. Newly diagnosed diabetes/hyperglycemia in hospitals: what should we do?. Endocr Pract 2006;12(Suppl 3):108-11
   PubMedGoogle Scholar
• Thompson CL, Dunn KC, Menon MC. Hyperglycemia in the hospital. Diabetes Spectr 2005;18:20-7
   Google Scholar
• Boyle PJ, Zrebiec J. Management of diabetes-related hypoglycemia. South Med J 2007;100:183-94
   PubMed Web of Science ®Google Scholar